GUARDIAN PHRMCY SERVICES-A
GRDNNYSETrading Snapshot
- Day Range
- $40.16 – $41.09
- 52-Week Range
- $26.34 – $48.33
- Volume (shares)
- 207,976
- Avg Volume (shares)
- —
- Shares Outstanding
- 63.3M
- Next Earnings
- 2026-11-05
Fundamentals Snapshot
- Annual Revenue
- $1.45B
- Last Q Revenue
- $352M
- P/E Ratio
- 38.0
- P/S Ratio
- 1.7x
- EPS (TTM)
- $1.02
- Dividend Yield
- —
- Dilution (1yr)
- +4.0%
GUARDIAN PHRMCY SERVICES-A
GRDN
StockOtter · stockotter.spaceAbout GUARDIAN PHRMCY SERVICES-A
Guardian Pharmacy Services, Inc. operates as a pharmaceutical service provider, delivering an extensive array of tech-driven solutions. These services are specifically crafted to enhance the care of residents within long-term health care facilities (LTCFs) across the United States. The company specializes in offering personalized clinical assistance, efficient drug distribution, and comprehensive administrative support. These provisions are particularly beneficial for individuals in less acute long-term care environments, such as assisted living communities, behavioral health centers, and group homes. To bolster its operations, the company offers Guardian Compass, a platform that generates insightful dashboards from its extensive data warehouse. This tool enables its network of local pharmacies to effectively strategize, monitor performance, and refine their business processes. Furthermore, Guardian Pharmacy Services develops dedicated GuardianShield Programs for LTCFs. The company was established in 2003 and is based in Atlanta, Georgia.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
Guardian Pharmacy Services, Inc. to Report Third Quarter 2026 Financial Results and Host Conference Call
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release third quarter 2026 financial results after market close on Thursday, November 5, 2026. Management will host a c
Bet on Winning DuPont Analysis & Pick 5 Top Stocks
Do you have more faith in DuPont analysis than simple ROE calculation? Tap CNXN, ECG, GRDN, EXPD and PBF.
Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Average Recommendation of “Moderate Buy” by Analysts
Guardian Pharmacy Services, Inc. (NYSE: GRDN - Get Free Report) has been given an average rating of "Moderate Buy" by the nine research firms that are presently covering the stock, Marketbeat.com reports. One analyst has
Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) has acquired assets from Tennessee-based Nautilus Pharmacy.
Guardian Pharmacy Services, Inc. $GRDN Shares Purchased by Bank of America Corp DE
Bank of America Corp DE increased its position in shares of Guardian Pharmacy Services, Inc. (NYSE: GRDN) by 86.1% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commis
Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will participate in the Jefferies Healthcare Services Conference, on Tuesday, September 15, 2026. Fred Burke, President and